PET/CT in Patients with Breast Cancer Treated with Immunotherapy.

Cancers (Basel) · 2023 · PMC10177398 · PMID 37174086

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

GeparNuevo also studied ICI with durvalumab in EBC, and although the addition increased pCR numerically, it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.